JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1992; 75:777-783
© 1992 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, S. C.
Right arrow Articles by Bishop, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, S. C.
Right arrow Articles by Bishop, M. J.

Efficacy of Anticholinergic and $bT-Adrenergic Agonist Treatment of Maximal Cholinergic Bronchospasm in Tracheally Intubated Rabbits

Sai Chuen Wu, MBSc, Jacob Hildebrandt, PhD, Pamela D. Isner, BS, David J. Pierson, MD, and Michael J. Bishop, MD

Departments of Anesthesiology, Medicine (Pulmonary and Critical Care), and Physiology and Biophysics, University of Washington School of Medicine, Seattle, Washington, and the Department of Anesthesiology, Chang Gung Memorial Hospital and Chang Gung Medical School, Linkou Medical Center, Linkou, Taiwan, Republic of China

Abstract

Cholinergically induced bronchoconstriction is thought to be a major cause of bronchospasm during anesthesia. We used tracheally intubated rabbits (4-mm endotracheal tube) stimulated with methacholine to assess the efficacy of β-adrenergic agonist and anticholinergic treatment in reversing the increases in respiratory system resistance. Four groups were compared: (a) inhaled metaproterenol, 20 puffs via metered dose inhaler (0.65 mg/puff); (b) inhaled ipratropium bromide, 20 puffs from a metered dose inhaler (18 µg/puff); (c) 2 mg of intravenous atropine; and (d) no treatment after methacholine challenge as a control group. Methacholine increased respiratory system resistance from 0.041 ± 0.001 (mean ± SEM) to 0.098 ± 0.006 cm H2O mL-1 s-1 (P < 0.001). Whereas β-adrenergic agonist treatment was ineffective in ameliorating bronchoconstriction, inhaled ipratropium bromide and atropine were highly effective, causing an 86%-88% reversal in the methacholine-induced increase in respiratory system resistance. Both these agents were also effective in improving dynamic compliance. We conclude that inhaled ipratropium bromide is effective in treating cholinergic bronchospasm even when administered via a small endotracheal tube and that the β-adrenergic agonist metaproterenol is ineffective in rabbits in the face of maximal cholinergic stimulation.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 1992 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1992 by the International Anesthesia Research Society.